The Torkzadeh Law Firm is currently investigating and accepting cases involving testosterone replacement therapy and any resulting cardiac event such as a heart attack or stroke.
The side effects of testosterone therapy made headlines over the past few months.
In January 2014, the Food and Drug Administration announced that it was investigating the safety of testosterone replacement drugs after reviewing several studies that show a significant increase in the risk of heart attack, stroke or other cardiac event.
The latest has been a new study published by the Public Library of Science, which found that testosterone replacement therapy may double or triple the risk of stroke, heart attack or pulmonary embolism. In the study, men who are 65 or older were found to have double the risk of heart attack within just 90 days of starting the testosterone therapy. Even more alarming is that in younger men, the risk of heart attack almost triples. The study by the Public Library of Science examined the medical records of more than 55,000 men.
The Journal of the American Medical Association found a 30% increased risk of heart attacks and stroke in men over 65 who start testosterone therapy and The New England Journal of Medicine found a substantial increase in cardiac problems men who used testosterone therapy.
Public Citizen, a consumer advocacy group, has examined 27 testosterone trial studies, of which 13 were funded by the drug companies. The drug company funded studies did not show an increase in cardiac events or heart problems. All 14 remaining trial studies, which were not funded by the drug companies, showed double the increase of cardiac problems.
The following is a list of brand name testosterone treatments: